Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes ...

For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their ...

Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...

Novo Nordisk chief executive Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the health care costs of the ...

Lars Fruergaard Jørgensen, Novo Nordisk's CEO, says his company is working to expand manufacturing to meet the supply ...

The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite ...

The CEO of Novo Nordisk is set to face pointed questions on Capitol Hill Tuesday about the prices of the Danish ...

In Senator Bernie Sanders's letter to chief executive Lars Fruergaard Jørgensen, he says drugmaker Novo Nordisk charges $969 ...

The Senate Health, Education, Labor and Pension committee, led by Vermont Sen. Bernie Sanders, is hearing testimony from Novo ...

Novo Nordisk CEO Lars Fruergaard Jorgensen will testify Tuesday before a Senate panel looking into the drug maker's pricing ...

U.S. senators questioned Novo Nordisk CEO Lars Fruergaard Jørgensen about the high costs of the company's GLP-1 drugs, which include popular weight-loss drugs Wegovy and Ozempic. It comes after North ...

Novo Nordisk CEO commits to exploring ways to make weight-loss drugs more affordable for U.S. patients after hearing from ...